Although Mbd4-null mice do not have increased rates of spontaneous tumorigenesis, a null mutation in Mbd4 on the ApcMin/+ cancer prone background confers a further decrease in survival time and greater tumor multiplicity relative to the ApcMin/+ single mutant [43, 44]. This evidence concerns the gene MBD4 and cancer.